Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
29.03
+0.22 (0.76%)
Mar 26, 2025, 10:01 AM EDT - Market open
Acadia Healthcare Company Revenue
In the year 2024, Acadia Healthcare Company had annual revenue of $3.15B with 7.69% growth. Acadia Healthcare Company had revenue of $774.24M in the quarter ending December 31, 2024, with 4.23% growth.
Revenue (ttm)
$3.15B
Revenue Growth
+7.69%
P/S Ratio
0.84
Revenue / Employee
$123,685
Employees
25,500
Market Cap
2.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | 225.23M | 7.69% |
| Dec 31, 2023 | 2.93B | 318.34M | 12.20% |
| Dec 31, 2022 | 2.61B | 296.01M | 12.79% |
| Dec 31, 2021 | 2.31B | 224.47M | 10.74% |
| Dec 31, 2020 | 2.09B | 81.55M | 4.06% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
ACHC News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc. (ACHC) And Encourages Stockholders to Connect - Accesswire
- 3 days ago - Acadia Healthcare Company, Inc. (ACHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Acadia Healthcare Company, Inc. (ACHC) Investors to Inquire about Securities Investigation - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Acadia Healthcare Company, Inc. (ACHC) And Encourages Shareholders to Reach Out - Accesswire
- 14 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 17 days ago - Acadia Healthcare Company, Inc. (ACHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 19 days ago - Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2033 - Business Wire